Monday, December 23, 2024
HomeTagsDavid Stamler

David Stamler

Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia

Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, announced that it has received approval in Australia from the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics